Provexis (LON:PXS) Issues Quarterly Earnings Results

Provexis (LON:PXS – Get Free Report) issued its earnings results on Thursday. The company reported GBX (0.02) EPS for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 49.45% and a negative net margin of 69.30%.

Provexis Trading Up 1.6%

Shares of LON PXS traded up GBX 0.01 during midday trading on Thursday, hitting GBX 0.94. The company’s stock had a trading volume of 580,714 shares, compared to its average volume of 1,962,177. The firm has a market capitalization of £22.05 million, a price-to-earnings ratio of -47.00 and a beta of 0.66. The stock has a fifty day moving average price of GBX 1.05 and a 200 day moving average price of GBX 1.07. Provexis has a one year low of GBX 0.55 and a one year high of GBX 1.55.

Get Provexis alerts:

Provexis Company Profile

(Get Free Report)

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.

Further Reading

• Five stocks we like better than Provexis
• Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
• JPMorgan Bets on Genius Sports as the Market Loses Patience
• Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
• First Watch’s Growth Story Meets a Reality Check

Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.